TrialLung cancer (Amsterdam, Netherlands)2013

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC).

Erin M Bertino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.